Rivier-consulting.ch

Liste des publications scientifiques de Laurent RIVIER
1. L. Rivier et P.E. Pilet (1971) Composés hallucinogènes indoliques naturels. Année
Biologique 10, 129-149.
2. L. Rivier and J.E. Lindgren (1972) Ayahuasca, the south-american hallucinogenic drink - an ethnobotanical and chemical investigation. Economic Botany 26, 101-129.
3. L. Rivier and P.E. Pilet (1974) Indolyl-3-acetic acid in cap and apex of maize roots : identification and quantification by mass fragmentography. Planta (Berlin) 120, 107-
112.
4. L. Rivier et P. Baumann (1976) La spectrométrie de masse en biologie et médecine.
Bulletin de la Société vaudoise des sciences naturelles 349, 1-18.
5. L. Rivier, H. Milon and P.E. Pilet (1977) Gas-chromatography mass-spectrometric determinations of abscisic acid levels in the cap and the apex of maize roots. Planta
(Berlin) 134, 23-27.
6. B. Holmstedt, J.E. Lindgren, L. Rivier and R.E. Schultes (1977) De plantis toxicariis e mundo novo tropicale commentationes XVII : Phytochemical examination of Spruce's
ethnobotanical collection of Anadenanthera peregrina. Botanical Museum Leaflets
Harvard University
25, 273-287.
7. R.E. Schultes, M.S. Blum, J.W. Daly, H.M. Fales, B. Holmstedt, D.M. Jerina, J.E.
Lindgren, C.W. Myers, T.C. Plowman, L. Rivier, T. Swain, O. Tovar, G.H.N. Towers
and J.W. Wheeler (1977) Ethnopharmacological studies of the flora and fauna of the
Pebas region of the peruvian amazon. R/V Alpha Helix Activity Report , National
Science Foundation
, p. 16.
8. B. Holmstedt, J.E. Lindgren, L. Rivier and T. Plowman (1979) Cocaine in blood of coca chewers. Botanical Museum Leaflets Harvard University 26, 199-201.
9. L. Rivier and J.G. Bruhn (1979) Editorial. Journal of Ethnopharmacology 1, 1-2.
10. B. Holmstedt, J.E. Lindgren, L. Rivier and T. Plowman (1979) Cocaine in blood of coca chewers. Journal of Ethnopharmacology 1, 69-78.
11. B. Holmstedt, J.E. Lindgren, L. Rivier and J. Ribeiro do Valle (1979) Ayahuasca, caapi o yagê - bebida alucinogena dos indios da bacia amazonica. Ciencia e Cultura 31,
1120-1124.
12. P.E. Pilet and L. Rivier (1980) Light and dark georeaction of maize roots : effect and endogenous levels of abscisic acid. Plant Science Letters 18, 201-206.
13. B. Holmstedt, J.E. Lindgren, L. Rivier, R.E. Schultes, T. Plowman and O. Towar (1980) Indole alkaloids in amazonian myristicaceae : field and laboratory research.
Botanical Museum Leaflets Harvard University 28, 215-234.
14. L. Rivier and P.E. Pilet (1981) ABA levels in the root tips of seven Zea mays varieties.
Phytochemistry 20, 17-19.
15. L. Rivier, P. Gaskin, K.-Y. S. Albone and J. MacMillan (1981) GC-MS identification of endogenous gibberellins and gibberellin-conjugates as their permethylated
derivatives. Phytochemistry 20, 687-692.
16. L. Rivier (1981) Introduction to a special issue on coca and cocaine. Journal of
Ethnopharmacology 3, 111-112.
17. L. Rivier (1981) Analysis of alkaloids in leaves of cultivated Erythroxylum and characterization of alkaline substances used during coca chewing. Journal of
Ethnopharmacology
3, 313-335.
18. P.E. Pilet and L. Rivier (1981) Abscisic acid distribution in horizontal maize root segments. Planta (Berlin) 153, 453-458.
19. M.S. Blum, L. Rivier and T. Plowman (1981) Fate of cocaine in the lymantriid Eloria noyesi, a predator of Erythroxylum coca. Phytochemistry 20, 2499-2500.
20. J.R.F. Allen, L. Rivier and P.E. Pilet (1982) Quantification of indol-3yl-acetic acid in pea and maize seedlings by gas chromatography-mass spectrometry. Phytochemistry
21
, 525-530.
21. J.R.F. Allen, J.E. Rebeaud, L. Rivier and P.E. Pilet (1982) Quantification of indol-3yl- acetic acid by GC-MS using deuterated labelled internal standards. In "Stable
Isotopes
", H.L. Schmidt, K. Heinzinger and H. Foerstel (Edts.) Analytical Chemistry
Symposia Serie Vol. 11, Elsevier : Amsterdam, 529-534.
22. L. Rivier and P.E. Pilet (1982) Quantitation of abscisic acid and its 2-trans isomer in plant tissues using a stable isotope dilution technique. In "Stable Isotopes", H.L.
Schmidt, K. Heinzinger and H. Foerstel (Edts.) Analytical Chemistry Symposia Serie
Vol. 11, Elsevier : Amsterdam, 535-541.
23. P. Baumann, L. Koeb, D. Tinguely and L. Rivier (1982) A method for the analysis of free, total plasma and saliva amitriptyline and nortriptyline by dialysis and GC-MS.
European Journal of Mass Spectrometry 2, 19-26.
24. M.J. Balik, L. Rivier and T. Plowman (1982) The effect of field preservation on alkaloid content of fresh coca leaves ( Erythroxylum spp.). Journal of
Ethnopharmacology
6, 287-291.
25. L. Rivier (1982) Une nouvelle technique de dosage biochimique : la GC-MS, progrès et quelques réflexions critiques. Dialectica 36, 23-28.
26. P. Baumann, L. Rivier and M. Perey (1983) Assay of tryptophan and related compounds as norharman derivatives by GC-MS in plasma. In "Recent Developments
in Mass Spectrometry in Biochemistry, Medicine and Environmental Research
",
A. Frigerio, edt. Vol. 8, Elsevier : Amsterdam, 185-190.
27. L. Rivier and P.E. Pilet (1983) Simultaneous gas chromatographic-mass spectrometry : determination of abscisic acid and indol-3yl-acetic acid in the same plant tissue using
2H-labelled internal standard. In "Recent Developments in Mass Spectrometry in
Biochemistry, Medicine and Environmental Research
", A. Frigerio (Edt.) Vol. 8,
Elsevier : Amsterdam, 219-231.
28. T. Plowman and L. Rivier (1983) Analyses of cocaine and cinnamoylcocaine in 31 Erythroxylum species. Annals of Botany 51, 641-659.
29. L. Rivier, J.F. Léonard and J.P. Cottier (1983) Rapid effect of osmotic stress on the content and exodiffusion of ABA in Zea mays roots. Plant Science Letters 31, 133-
137.
30. P. Baumann, L. Koeb and L. Rivier (1984) Beta-carboline levels in blood of smokers and non-smokers. In "Progress in Tryptophan and Serotonin Research ". H.G.
Schlossberger, W. Kochen, B. Linzen and H. Steinhart (Edts.) De Gruyter : Berlin,
491-501.
31. L. Rivier and J.G. Bruhn (1985) Editorial. Journal of Ethnopharmacology 13, 1.
32. P.A.G.M. de Smet and L. Rivier (1985) Intoxicating snuffs of the Venezuelan Piaroa indians. Journal of Psychoactive Drugs, 17, 93-103.
33. J. Davies, E. Jensen, O. Junttila, L. Rivier et A. Crozier (1985) Identification of Endogenous gibberellins from Salix pentandra . Plant Physiology, 78, 473-476 .
34. L. Rivier and M. Saugy (1986) Chemical Ionization Mass Spectrometry of Indol-3yl- Acetic Acid and Cis-Abscisic Acid : evaluation of negative ions detection and
quantification of Cis-Abscisic Acid in growing maize roots. Journal of Plant Growth
Regulation
, 5, 1-16 .
35. L. Rivier (1986) GC-MS of auxins. In "Gas Chromatography/Mass
Spectrometry".Modern Methods in Plant Analysis New Serie Vol. 3. H.-F. Linskens
and J.F. Jackson (Edts.) Springer : Heidelberg, 146-188 .
36. E. Jensen, L. Rivier, O. Junttila and A. Crozier (1986) Identification of Abscisic acid from shoots of Salix pentandra, Physiologia Plantarum,66, 406-408.
37. L. Rivier, J.G. Bruhn, M. Malone and T. Plowman (1986) Editorial : Creation of the International Society for Ethnopharmacology (ISEP), Journal of Ethnopharmacology
18
, 1.
38. L. Rivier and A. Crozier, Editors (1987) Principles and practice of plant hormones
analyses. Academic Press : London. Biological Techniques Series, 2 Vol, 401 pp.
39. M. Roulet, R. Laurini and L. Rivier (1988) Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea. J. of Pediatrics 112, 433 - 436.
40. Ch. Benedek and L. Rivier (1989) Evidence for the presence of tetrodotoxin in a powder used in Haiti for zombification. Toxicon, 27, 475 - 482.
41. L. Rivier and Ch. Benedek (1989) Detection of Tetrodotoxin in an ethnic preparation.
Proceedings of the TIAFT meeting, University Press : Groningen. D.R.A. Uges and
R.A. de Zeeuw (Edts.), 480-490.
42. L. Rivier and M. Saugy (1989) Alcohol oxidase enzyme sensor for blood ethanol determinations. Proceedings of the TIAFT meeting, University Press : Groningen.
D.R.A. Uges and R.A. de Zeeuw (Edts.), 491-498.
43. P.A.G.M. de Smet and L. Rivier (1989) A general outlook on ethnopharmacology .
Journal of Ethnopharmacology 25, 127-138.
44. M. Saugy and L. Rivier (1990) GC-MS quantifications of free and ester indol-3yl- acetic acids in relation to root growth and gravitropism. R.P. Pharis et S.B. Rood
(Edts.), Proceedings of the 13th International Conference on Plant Growth
Substances 1988, Calgary
, Springer : Berlin, Heidelberg, New York, 441-449.
45. D. Wyss, L. Rivier, HR. Gujer, F. Paccaud, P. Magnenat and B. Yersin (1990) Characteristics of 167 consecutive traffic accident victims with special reference to
alcohol intoxication : a prospective emergency room study. Soz Preventivmed 35, 89-
93.
46. Ph. Meuwly, A. Munafo, L. Rivier and M. Saugy (1991) Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in
human body fluids and its confirmation by gas chromatography-mass spectrometry. J.
Chromatography B
564, 567-578 .
47. L. Rivier , C. Giroud et C. Staub. (1991) Caractérisation de la prise d'opiacés (héroïne, morphine, codéine et éthylmorphine) par l'intermédiaire de l'analyse d'urine : quels
critères adopter ?. Praxis, Revue suisse de Médecine 80, 1135-1139.
48. R. Anton and L. Rivier (1991) Introduction to "Ethnopharmacology 1990" : Proceedings of the First International Congress on Ethnopharmacology, Strasbourg,
France, June 1990. Journal of Ethnopharmacology 32, 1-2.
49. C. Cardis, M. Saugy and L. Rivier. Diuretics in Doping Controls (1991) Caracterisation in Human Urine by Using Gas Chromatographiy - Chemical Ionisation Mass
Spectrometry. Proceedings of the TIAFT Meeting, Copenhagen, 271-285.
50. C. Giroud, C. Cardis, M. Saugy and L. Rivier (1991) Positive Urine for Doping Agents after Receiving a Single Capsule of an Ephedra Phytotherapeutic Preparation
Proceedings of the TIAFT Meeting, Copenhagen, 221-230
51. B. Yersin, D. Wyss, V. Koehn, L. Rivier, HR Gujer, F. Paccaud and P. Magnenat (1992) Detrimental effect of accute alcohol intoxication on severity of non-fatal injuries in male traffic accident victims : a cross-sectional study. Soz. Praeventivmed.
37, 118-123.
52. L. Rivier, M. Saugy and E. Levaine-Horvath. (1992) Is Computerized GC-MS Useful for the Detection of Benzodiazepines in Forensic Cases ? In "Forensic Toxicology",
John S. Oliver (Edt.) Edinburgh : Scottish Academic Press, 196-202.
53. E. Horvath and L. Rivier (1992) Chloral Hydrate, a 100 years old toxic drug still of actiality. In "Forensic Toxicology", John S. Oliver (Edt.) Edinburgh : Scottish
Academic Press, 235-239.
54. D. Cantoni and L. Rivier. (1992) Analysis of the secretions from the flank glands of 3 shrews species and their possible functions as a social context. In "Chemical Signals
in Vertebrates VI
", R.L. Doty and D. Müller-Schwarze (Edts.), New York : Plenum
Press, 99-106.
55. E. Roulet Perez, P. Maeder, L. Rivier and T. Deonna (1992) Toxic Leucoencephalopathy after heroin ingestion in a 2 1/2 year old Child. Lancet 340, 729.
56. L. Rivier (1992) Détection de la toxicomanie : sur la trace de 100 stupéfiants. UNI-
Lausanne 72, 51-52.
57. M. Saugy and L. Rivier (1992) Sport de haut niveau : la Suisse a son laboratoire anti- dopage. UNI-Lausanne 72, 53-55.
58. M. Saugy, C. Cardis, L. Rivier et G.-A. Carrel (1993) Hormone de croissance : LUC volley-ball, équipe témoin, UNI-Lausanne, spécial sports, 46-49.
59. C. Cardis, M. Saugy et L. Rivier (1993) L'Unité d'Analyse du Dopage (UAD) de l'Université de Lausanne. Bilan des premiers mois d'activité, UNI-Lausanne, spécial
sports, 50-51.
60. C. Giroud, T. Colassis, L. Rivier et E. Ottinger (1993) Cocaïne et alcool : un cocktail explosif !, Praxis 15, 441-446.
61. C. Giroud, M. Saugy, T. Colassis and L. Rivier (1993) What criteria should be used for forensic drug testing of alkyl-morphines ? dans Nagata T., ed, Proceedings of the
30th international meeting of the International Association of Forensic
toxicologists (TIAFT)
, Yoyodo Printing Kaisha Ltd, Fukuoka, Japan,. 329-333.
62. L. Rivier (1994) Ethnopharmacology of LSD and related compounds. In "5o years of
LSD : states of the art and perspectives of hallucinogens". Swiss Academy of
Medical Sciences (Edt.) : Basel, Parthenon Publ. : Carnforth, 43-56.
63. M. Augsburger and L. Rivier. (1994) Drug screening in whole blood sample by automated extractive dialysis and gas chromatography. Toxicorama 4, 23-32,.
64. M. Augsburger, C. Giroud, P. Lucchini and L. Rivier (1994) Suicide involving zolpidem and hypothermia. In : Contributions to Forensic Toxicology. R. K. Muller
(Edt.) Molinapress : Leipzig, 18-22.
65. M. Augsburger et L. Rivier (1994) Recherche de drogues et médicaments dans le sang par dialyse extractive automatisée et chromatographie en phase gazeuse. Toxicorama 4
, 23-32.
66. C. Giroud, T. Colassis and L. Rivier (1994) Forensic screening of cocaine, ethylcocaine and their respective metabolites in blood and urine from drug abusers in Switzerland.
Toxicorama 6, 19-29.
67. C. Grunauer, M. Saugy and L. Rivier (1994) Direct Extractive Methylation and Automatic GC-MS Screening and Identification of Drugs of Abuse and Other
Compounds of Potential Abuse in Sport. Proceedings of the 31st international
meeting of the International Association of Forensic toxicologists (TIAFT)
,
Leipzig : MOLINApress , 419-422.
68. L. Rivier, M. Saugy and M. Augsburger (1994) Automated Dialysis : a new approach to prepare blood samples for systematic drug analysis in forensic and doping controls.
Blood samples in doping control. Second International Symposium on drugs in
Sports - Lillehammer 1993,
Pensumtjeneste (On Demand Publishing), Oslo, 165-
172.
69. M. Saugy, C. Cardis, M. Caron, F. Gomez, S. Landolt and L. Rivier (1994) Urinary human growth hormone (U-HGH) : Alternative to hGH blood test in doping controls ?
Blood samples in doping control. Second International Symposium on drugs in
Sports - Lillehammer 1993,
Pensumtjeneste (On Demand Publishing), Oslo, 53-64.
70. C. Giroud, A. Sutter, M. Augsburger and L. Rivier (1995) Fatal strychnine self- poisonning in hospital. In : Advances in Forensic Sciences Vol. 5. Jacob B. et Bonte
W. (Edts.) Köster : Berlin , 108-111.
71. C. Giroud, M. Augsburger and L. Rivier (1995) The Tradegy of the sect of the "Ordre du Temple Solaire" (Cheiry-Salvan, Switzerland, 48 deaths) : Analytical strategy and
main toxicological findings. In : Aspects on Forensic Toxicology. Kovatsis A.V. et
Tsoukali-Papadopoulou H. (Edts) Erasmos : Thessaloniki, 243-248.
72. C. Giroud, P. Lucchini and L. Rivier (1995) An Intoplicine Fatality. In : Bridging the
World of Forensic Toxicology. V. Spiehler (Edt.) Proceedings of the 1994 SOFT-
TIAFT international symposium, Tampa, U.S.A., 113-120.
73. L. Rivier, M. Saugy and C. Cardis (1995) Endogenous doping agents detection : State- of-the-art and new strategies as demonstrated by the growth hormone problem. In :
Aspects on Forensic Toxicology. Kovatsis A.V. et Tsoukali-Papadopoulou H. (Edts)
Erasmos : Thessaloniki,. 83-87.
74. L. Rivier and M. Saugy (1995). Systematic Drug Identification. in "Encyclopedia of
Analytical Science". Academic Press : London, 1594-1606.
75. L. Rivier (1995)Conduite automobile et Toxicomanie en Suisse. Actes du Symposium
STRATOX II. A. Traqui (Edt.). Strasbourg : IUML, 161-169.
76. C. Giroud, M. Augsburger, Guignard N., Mahdad A., Proccureur A, Steiger C et L.
Rivier (1995) Les 48 victimes du drame de la secte de l’Ordre du Temple Solaire :
notre stratégie pour l’analyse toxicologique systématique. Actes du Symposium
STRATOX II, A. Traqui (Edt.). Strasbourg : IUML, 243-248.
77. L. Rivier, M. Saugy and A. Sutter (1995) Forensic actuality of anabolic steroid violence and addiction. In : Bridging the World of Forensic Toxicology. V. Spiehler
(Edt.) Proceedings of the 1994 SOFT-TIAFT international symposium, Tampa, U.S.A.,
292-301.
78. M. Saugy, C. Cardis and L. Rivier (1995) Urinary human growth hormone (U-hGH) I.
Measurements in non-athlete volunteers after intra-muscular or subcutaneous hGH
injections. In : Recent Advances in Doping Analysis Vol. 2, M. Donike, H. Geyer,
A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss,
213-222.
79. M. Saugy, C. Cardis, L. Rivier, G. Brisson., C. Ayotte, P. Hemmersbach, E. Haug and J. Segura (1995) Urinary human growth hormone (U-hGH) II. Measurements in
competition tests . More the expression of the renal function than the endocrinological
status. In : Recent Advances in Doping Analysis Vol. 2, M. Donike, H. Geyer, A.
Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss ,
223-234.
80. C. Giroud et L. Rivier (1995) Problèmes médico-légaux posés par la commercialisation de l’huile de chanvre en Suisse. Toxicorama 7, 15-23.
81. C. Giroud, W. Eichenberger and L. Rivier (1995) Hemp seed oil : a new source of edible oil for Switzerland ? Biol. Chem. Hoppe-Seyler 376, S52.
82. C. Giroud and L. Rivier (1996) Characterization of different "Swiss" Hemp exhibits with regard to their Cannabinoid Content. TIAFT Bulletin 26, 30-34.
83. M. Saugy, C. Cardis, C. Schweizer, N. Dimo-Simonin, F. Grange, C. Brandt- Casadevall and L. Rivier (1996) Identification problems of urine samples in doping
controls resolved by DNA-PCR.In : Recent Advances in Doping Analysis Vol. 3, M.
Donike, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport
und Buch Strauss 337-347.
84. M. Saugy, C. Cardis, C. Schweizer, J.-L. Veuthey and L. Rivier (1996) The detection of human growth hormone doping in urine : Out of competition tests are necessary.
Journal of Chromatography B 687, 201-211.
85. D. Cantoni, L. Favre, F. Tencalla, P. Croset, F. Morgenthaler, G. Camarda, C. Ruchet, L. Rivier and P. Vogel (1996) Intra- and interindividual variation in flank gland
secretions of free-ranging shrews Crocidura russula. J. Chemical Ecology 22, 1669-
1688.
86. D.D. Soejarto, L. Rivier, C. Gyllenhaal and N.R. Farnsworth (Edts.) (1996) Intellectual property rights, naturally derived bioactive compounds and resourceconservation. Amsterdam : Elsevier Science, 336 pp.
87. M. Augsburger and L. Rivier (1997) Drugs and alcohol among suspected impared drivers in Canton de Vaud (Switzerland). Forensic Science International 85, 95-107.
88. F. Sadeghipour, E. Varesio, C. Giroud, L. Rivier and J.-L. Veuthey (1997) Analysis of Amphetamines by Capillary Electrophoresis and Liquid Chromatography - Application
to Drug Seizures and Cross-validation. Forensic Science International 86, 1-13.
89. C. Giroud, M. Augsburger, F. Sadeghhipour, E. Varesio, J.-L. Veuthey et L. Rivier (1997) Ecstasy - La situation en Suisse romande. Praxis 86, 510-523.
90. F. Sadeghipour, C. Giroud, L. Rivier and J.-L. Veuthey (1997) Rapid determination of amphetamines by high-performance liquid chromatography with UV detection. J.
Chromatogr. A
761, 71-78.
91. C. Giroud, M. Augsburger, F. Sadeghipour, E. Varesio, J.-L. Veuthey, L. Rivier et P.
Mangin (1997) Ecstasy and « raves » en Suisse romande. Toxicorama 9, 113-122.
92. L. Rivier (1997) Between gastronomy and sorcery : the ethnotoxicological role of tetrodotoxin. In : Healing yesterday and today, tomorrow ? Pproceedings of the 1stInternational conference of anthropology and history of health and disease. A. Guerci(Edt.), CD-Rom and printed form. Erga multimedia, 3 pages 93. L. Rivier (1997) Activities of the unit for forensic chemistry and toxicology of the Swiss society of legal medicine. Chimia 51, 780-781.
94. C. Schweizer, C. Cardis, M. Cauderay, L. Rivier and M. Saugy (1997) T/E ratio variations through puberty in male adolescents. In : Recent Advances in Doping
Analysis Vol. 4.
, W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke
(edts.), Köln : Verlag Sport und Buch Strauss , 159-171.
95. C. Cardis, C. Schweizer, M. Saugy and L. Rivier (1997) Ketoconazol test : blood versus urine values. In : Recent Advances in Doping Analysis Vol. 4. , W. Schänzer,
H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und
Buch Strauss , 305-317.
96. A. Durussel, C. Cardis, C. Schweizer, L. Rivier, G. Brisson and M. Saugy (1997) Influence of creatine intake upon biochemical parameters in urine. In : Recent
Advances in Doping Analysis Vol. 4.
, W. Schänzer, H. Geyer, A. Gotzmmann and
U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss , 323-333.
97. M. Augsburger, C. Giroud, L. Rivier and P. Mangin (1997) Analytical strategy for analysis of drugs in biological samples in case of DUID. In : Alcohol, Drugs and
Trafic Safety - T’97
3, 1421-1426.
98. L. Rivier, M. Augsburger et P. Mangin (1997) Les drogues détectées chez 641 conducteurs suspectés d’incapacité à conduire : nature des substances et incidence des
interactions. J. Médecine légale et Droit médical 40, 601-605.
99. C. Giroud, M. Augsburger, B. Horisberger, P. Lucchini, L. Rivier et P. Mangin (1997) Suicide assisté par l’association „EXIT“ : aspects toxicologiques et médico-légaux.
Toxicorama Numéro spécial, 359-362.
100. M. Augsburger, C. Giroud, L. Rivier, A. Traqui and P. Mangin (1998) Car crash after massive ingestion of digoxin and midazolam. Intern. J. Legal Medicine 111, 205-207.
101. C. Giroud, M. Augsburger, L. Rivier and P. Mangin (1998) Hemp tea versus hemp milk : subjective effects and elimination studies of THC and its main metabolites.
Proceedings of the 35th international meeting of the International Association of
Forensic toxicologists (TIAFT)
, Cleub : Padova, Italy, 112-121.
102. L. Rivier (1998) The use of high selectivity MS techniques to increase the retrospectibility of the detection of the abuse of selected doping agents. Proceedings
of the 35th international meeting of the International Association of Forensic
toxicologists (TIAFT)
, Cleub : Padova, Italy, 191-198.
103. M. Augsburger, L. Rivier and P. Mangin (1998) Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine. J. Pharmaceutical
and biomedical analysis
18, 681-687.
104. C. Giroud, M. Augsburger, L. Rivier, P. Mangin, F. Sadeghipour, E. Varesio, J.-L.
Veuthey and P. Kamalaprija (1998) 2C-B : A new psychoactive phenylethylamine
recently discovered in ecstasy tablets sold on the Swiss black market. J. Analytical
Toxicology
22, 345-354.
105. C. Schweizer, C. Cardis, M. Saugy and L. Rivier (1998) Nicotine in sports : use and abuse. In : Recent Advances in Doping Analysis Vol. 5. , W. Schänzer, H. Geyer, A.
Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag Sport und Buch Strauss ,
269-277.
106. C. Giroud, A. Broillet, M. Augsburger, W. Bernhard, L. Rivier et P. Mangin (1999) Bref historique de la culture récente du chanvre en Suisse et problèmes médico-légaux
engendrés par cette culture. Praxis 88, 113-122.
107. C. Giroud, A. Broillet, M. Augsburger, A. Ménétrey, W. Bernhard, L. Rivier and P.
Mangin (1999) “Cannabis sativa ssp. Helvetica” or the serial thriller of hemp in
Switzerland. Toxicorama 11, 51-58.
108. C. Giroud, M. Augsburger, B. Horisberger, P. Lucchini, L. Rivier and P. Mangin (1999) Exit association - mediated suicide : Toxicologic and forensic aspects. Am. J.
Forensic Medicine and Pathology
20, 40-44.
109. A. Dienes-Nagy, L. Rivier, C. Giroud, M. Augsburger and P. Mangin (1999) Method for auntification of morphine and its 3- and 6-glucuronides, codeine, codeine
glucuronide and 6-mono-acetylmorphine in human blood by liquid chromatography-
electrospray mass spectrometry for routine analysis in forensic toxicology. J.
Chromatogr. A
854, 109-118.
110. N. Robinson, C. Cardis, A. Dienes, C. Schweizer, M. Saugy and L. Rivier (1999) Immunoaffinity chromatography combined with ion trap technique in order to detect
traces of 19-norandrosterone. In : Recent Advances in Doping Analysis Vol. 6. , W.
Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag
Sport und Buch Strauss, 131-143.
111. C. Schweizer, , C. Cardis, M. Cauderay, L. Rivier and M. Saugy (1999) Profile variations through puberty in young adolescent girls. In : Recent Advances in Doping
Analysis Vol. 6.
, W. Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke
(edts.),Köln : Verlag Sport und Buch Strauss, 205-221.
112. L. Rivier and M. Saugy (1999) Peptide hormones abuse in sport : State of the art in the detection of growth hormone and erythropoietin. J. Toxicol. - Toxin reviews 18,
145-176.
113. L. Rivier (1999) Une zone grise dans le dopage des sportifs : les substances ergogènes. Médecine et Hygiène 57, 2034-2041.
114. L. Rivier (1999) Possibilities and restraints of the doping laboratory. Proceedings of
the 6th congress of equine medicine and surgery, P. Chuit (Edt.), Geneva, 56-62
115. M. Saugy, N. Robinson, C. Cardis, C. Schweizer, L. Rivier, P. Mangin, C. Ayotte and J. Dvorak (1999) Nandrolone metabolites in football players : Utility for in and
out of competition tests. In : Recent Advances in Doping Analysis Vol. 7. , W.
Schänzer, H. Geyer, A. Gotzmmann and U. Marek-Engelke (edts.), Köln : Verlag
Sport und Buch Strauss , 95-108.
116. C. Giroud, F. Felber, M. Augsburger, B. Horisberger, L. Rivier and P. Mangin (1999) Salvia divinorum Epling and Jativa, a vision-inducing mint recently discovered
in Switzerland. TIAFT Bulletin 29, 19-20.
117. C. Giroud, F. Felber, M. Augsburger, B. Horisberger, L. Rivier and P. Mangin (1999) Salvia divinorum : an hallucinogenic mint which might become a new
recreational drug in Switzerland. Forensic Science International 112, 143-150.
118. L. Rivier et P. Mangin (1999) Principaux produits dopants et leurs effets secondaires.
Une compilation préparée pour le compte de l’Union cycliste internationale. Lausanne: UCI, 35 pages (traduit en anglais, allemand, japonais et hongrois).
119. L. Rivier et P. Mangin (1999) Techniques for analytical testing in sport doping with unconventional samples. Une expertise préparée à l’attention de l’Office fédéral dessports, Macolin, 20 pages.
120. L. Rivier (2000) Is there a place for hair analysis in doping controls ? Forensic
Science International 107, 309-323.
121. L. Rivier (2000) Doping testing on alternative biological matrixes. Biology of Sport
17, 87-106.
122. L. Rivier (2000) Les produits dopants de demain. Annales de Toxicologie
analytique 12, 79-89.
123. L. Rivier (2000) Techniques for analytical testing of unconventional samples. In “Baillière’s Best Practice and research in clinical endocrinology and metabolism
(Special issue on Doping in Sport, P.E. Mullis, Guest Editor) 14, 147-165.
124. L. Rivier, C. Cardis and P. Mangin (2000) Equine Drug Testing. Encyclopedia of
Toxicology, Academic Press, 6 pages.
125. L. Rivier (2000) Editorial. J. Ethnopharmacol. 73, iii
126. O. Beck et L. Rivier (2000) European urine drug testing contrast with U.S. practices.
Clinical & Forensic Toxicology News June, 1, 4-5.
127. M. Kamber, N. Baume, M. Saugy et L. Rivier (2001) Nutritional supplements as a source for positive doping cases ? J. Sport Nutr. & Exercise Metabolism, 11, 258 -
263.
128. L. Rivier et P. Mangin (accepted for publication 2001) Le dépistage analytique systématique en laboratoire du dopage sportif au moyen de matrices biologiques
alternatives à l’urine. Revue Médecine du sport, 15 pages
129. K. Fluri, L. Rivier, A. Dienes-Nagy, C. You, A. Maître, C. Schweizer, M. Saugy et P. Mangin (2001) Method for confirmation of synthetic corticosteroids in doping
urine samples by liquid chromatography - electrospray ionisation mass spectrometry.
J. Chromatogr. A. 926, 87-95.
130. H. Hilleret, P. Voirol, Ph. Bovier, P. Giannakopoulos, D. Zullino, P. Baumann, Ch.
Giroud, L. Rivier et Ch. B. Eap (2002) Very long Half-life of paroxetine following
intoxication in an extensive cytochrome P4502D6 metabolizer : A case report.
Therapeutic Drug Monit. In press.
131. L. Rivier (2002) New trends in doping analysis. Chimia (in press) 12 pp.
132. L. Rivier (sumitted) Laboratory technology. In “Medico-legal of drugs” M. Burns 133. L. Rivier, T. Mellingsaeter and E. Jensen (in preparation) Detection of Perfluorocarbones by Head Space Gas Chromatography - Mass Spectrometry in
Blood Samples. J. Analytical Toxicology.
134. L. Rivier (in preparation) Fiabilité des tests de dépistage de la consommation de drogues chez les adolescents. Praxis.

Source: http://www.rivier-consulting.ch/dossier/LIST_Publ-LR-2002.pdf

Microsoft word - sry vuosikokouksen 2014 ohjelma-1.docx

SRY:n vuosikokous Helsingissä 23.-24.01.2014 Kalastajatorppa Torstai 23.01.2014 12.00 - 12.05 Cochrane-katsausten tekeminen ja käyttö kliinisessä työssä Abstrakteja I (kesto 10 min sisältäen keskustelun) 12.50-13.00 Kalle Aaltonen: Rates of serious infections and malignancies among rheumatoid arthritis patients receiving either TNF-blocker or rituximab therapy 13.00-13.10 Heikki Vall

Eye 1-2006.qxd

M A R K E T I N G De kracht van kwaliteit Kwaliteit wordt in marketing- land vaak vertaald als ‘beter zijn’ dan de concurrent. Maar dat is in deze tijd van alleen maar ‘betere’ producten ach- terhaald. Welke invulling van het begrip ‘kwaliteit’ sluit wél aan bij de consument van vandaag en morgen? Wat is een kwalitatief concept? Vroegerkon je als concept

Copyright © 2010-2014 Online pdf catalog